1 |
R Development Core Team (2010). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna.
|
2 |
Rodrigues J, Cancho VG, de Castro M, and Louzada-Neto F (2009). On the unification of long-term survival models, Statistics & Probability Letters, 79, 753-759.
DOI
|
3 |
Rucker G and Messerer D (1988). Remission duration: an example of interval-censored observations, Statistics in Medicine, 7, 1139-1145.
DOI
|
4 |
Spiegelhalter DJ, Best NG, Carlin BP, and van der Linde A (2002). Bayesian measures of model complexity and fit, Journal of the Royal Statistical Society B (Statistical Methodology), 64, 583-639.
DOI
|
5 |
Sun X and Chen C (2010). Comparison of Finkelstein's method with the conventional approach for interval-censored data analysis, Statistics in Biopharmaceutical Research, 2, 97-108.
DOI
|
6 |
Weiss R (1996). An approach to Bayesian sensitivity analysis, Journal of the Royal Statistical Society Series B (Methodological), 58, 739-750.
DOI
|
7 |
Xiang L, Ma X, and Yau KK (2011). Mixture cure model with random effects for clustered interval-censored survival data, Statistics in Medicine, 30, 995-1006.
|
8 |
Yakovlev AY and Tsodikov AD (1996). Stochastic Models of Tumor Latency and Their Biostatistical Applications, World Scientific, Singapore.
|
9 |
Yau KKW and Ng ASK (2001). Long-term survivor mixture model with random effects: application to a multi-centre clinical trial of carcinoma, Statistics in Medicine, 20, 1591-1607.
DOI
|
10 |
Zeng D, Yin G, and Ibrahim JG (2006). Semiparametric transformation models for survival data with a cure fraction, Journal of the American Statistical Association, 101, 670-684.
DOI
|
11 |
Besag J (1974). Spatial interaction and the statistical analysis of lattice systems, Journal of the Royal Statistical Society, Series B (Methodological), 36, 192-236.
DOI
|
12 |
Banerjee S and Carlin BP (2004). Parametric spatial cure rate models for interval-censored time-torelapse data, Biometrics, 60, 268-275.
DOI
|
13 |
Bennett S (1983). Analysis of survival data by the proportional odds model, Statistics in Medicine, 2, 273-277.
DOI
|
14 |
Berkson J and Gage RP (1952). Survival curve for cancer patients following treatment, Journal of the American Statistical Association, 47, 501-515.
DOI
|
15 |
Cancho VG, Ortega EMM, and Paula GA (2010). On estimation and influence diagnostics for log-Birnbaum-Saunders Student-t regression models: full Bayesian analysis, Journal of Statistical Planning and Inference, 140, 2486-2496.
DOI
|
16 |
Carlin BP and Banerjee S (2003). Hierarchical multivariate CAR models for spatio-temporally correlated survival data, Bayesian Statistics, 7, 45-63.
|
17 |
Chen MH, Ibrahim JG, and Sinha D (1999). A new Bayesian model for survival data with a surviving fraction, Journal of the American Statistical Association, 94, 909-919.
DOI
|
18 |
Dey DK and Birmiwal LR (1994). Robust Bayesian analysis using divergence measures, Statistics & Probability Letters, 20, 287-294.
DOI
|
19 |
Collett D (1994). Modelling survival data. In D Collett (Ed), Modelling Survival Data in Medical Research (pp. 53-60), Springer, New York.
|
20 |
Cooner F, Banerjee S, Carlin BP, and Sinha D (2007). Flexible cure rate modeling under latent activation schemes, Journal of the American Statistical Association, 102, 560-572.
DOI
|
21 |
Finkelstein DM (1986). A proportional Hazards model for interval-censored failure time data, Biometrics, 42, 845-854.
DOI
|
22 |
Gamerman D and Lopes HF (2006). Markov Chain Monte Carlo: Stochastic Simulation for Bayesian Inference (2nd ed.), Chapman & Hall/CRC, Boca Raton.
|
23 |
Gelfand AE and Vounatsou P (2003). Proper multivariate conditional autoregressive models for spatial data analysis, Biostatistics, 4, 11-15.
DOI
|
24 |
Geweke J (1992). Evaluating the accuracy of sampling-based approaches to calculating posterior moments. In JM Bernardo, J Berger, AP Dawid, and JFM Smith (Eds), Bayesian Statistics 4 (pp. 169-193), Clarendon Press, Oxford.
|
25 |
Gu Y, Sinha D, and Banerjee S (2011). Analysis of cure rate survival data under proportional odds model, Lifetime Data Analysis, 17, 123-134.
DOI
|
26 |
Hu T and Xiang L (2013). Efficient estimation for semiparametric cure models with interval-censored data, Journal of Multivariate Analysis, 121, 139-151.
DOI
|
27 |
Ma X and Xiang L (2013). Testing for the presence of a cure fraction in clustered interval-censored survival data, Australian & New Zealand Journal of Statistics, 55, 173-190.
DOI
|
28 |
Cook RD and Weisberg S (1982). Residuals and Influence in Regression, Chapman & Hall/CRC, FL.
|
29 |
Ibrahim JG, Chen MH, and Sinha D (2001). Bayesian Survival Analysis, Springer, New York.
|
30 |
Lindsey JC and Ryan LM (1998). Methods for interval-censored data, Statistics in Medicine, 17, 219-238.
DOI
|
31 |
Murray RP, Anthonisen NR, Connett JE, et al. (1998). Effects of multiple attempts to quit smoking and relapses to smoking on pulmonary function, Journal of Clinical Epidemiology, 51, 1317-1326.
DOI
|
32 |
Pan C, Cai B, Wang L, and Lin X (2014). Bayesian semiparametric model for spatially correlated interval-censored survival data, Computational Statistics & Data Analysis, 74, 198-208.
DOI
|
33 |
Peng F and Dey DK (1995). Bayesian analysis of outlier problems using divergence measures, Canadian Journal of Statistics, 23, 199-213.
DOI
|
34 |
Peto R (1973). Experimental survival curves for interval-censored data. Journal of the Royal Statistical Society Series C (Applied Statistics), 22, 86-91.
|
35 |
Plummer M, Best N, Cowles K, and Vines K (2005). Output analysis and diagnostics for MCMC: R package version 0.10-3, Retrieved November 2, 2017, from: http://cran.rproject.org
|